Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Myeloperoxidase Antikörper

Dieser Anti-Myeloperoxidase Antikörper ist ein Maus Monoklonal Antikörper zur Detektion von Myeloperoxidase in FACS und IHC (fro). Geeignet für Human und Ratte.
Produktnummer ABIN187335

Kurzübersicht für Myeloperoxidase Antikörper (ABIN187335)

Target

Alle Myeloperoxidase (MPO) Antikörper anzeigen
Myeloperoxidase (MPO)

Reaktivität

  • 192
  • 62
  • 53
  • 8
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human, Ratte

Wirt

  • 150
  • 82
  • 1
  • 1
  • 1
Maus

Klonalität

  • 120
  • 115
Monoklonal

Konjugat

  • 101
  • 30
  • 28
  • 11
  • 9
  • 9
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Myeloperoxidase Antikörper ist unkonjugiert

Applikation

  • 140
  • 87
  • 82
  • 60
  • 46
  • 43
  • 34
  • 18
  • 15
  • 14
  • 14
  • 13
  • 10
  • 7
  • 7
  • 5
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro))

Klon

8F4
  • Spezifität

    Monoclonal antibody 8F4 reacts with MPO. Species Reactivity: Human and rat. Others not tested.

    Sterilität

    0.2 μm filtered

    Isotyp

    IgG1
  • Applikationshinweise

    Flow Cytometry: The typical starting dilution is 1:10. Immunohistochemistry: (Frozen sections)-The typical starting dilution is 1:10. The optimal dilution for a specific application should be determined by the researcher.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    1 ml containing 100 µg IgG in PBS with 0.1% BSA. The antibody solution was filtered through a 0.2 micron filter.

    Lagerung

    4 °C
  • Target

    Myeloperoxidase (MPO)

    Andere Bezeichnung

    Myeloperoxidase

    Hintergrund

    Myeloperoxidase (MPO) is a glycoprotein with an alpha2beta2 heteromultimer expressed in all cells of the myeloid lineage. MPO is abundantly present in azurophilic granules of polymorphonuclear neutrophils. It is an important enzyme used during phagocytic lysis of engulfed foreign particles which takes part in the defense of the organism through production of hypochlorous acid (HOCl), a potent oxidant. MPO is rapidly released by activated polymorphonuclear neutrophils. Involvement of MPO has been described in numerous diseases such as atherosclerosis, lung cancer, Alzheimer's disease and multiple sclerosis. Autoimmune antibodies to MPO are involved in Wegeners disease. Since the discovery of MPO deficiency, initially regarded as rare and restricted to patients suffering from severe infections, MPO has attracted more clinical attention. In experimental studies antibodies to MPO can be used for various purposes ranging from flow cytometric analysis to detection of polymorphonuclear neutrophils in tissue sections.

    Pathways

    Chromatin Binding
Sie sind hier:
Chat with us!